Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.


BACKGROUND Standard therapy to prevent recurrent venous thromboembolism includes 3 to 12 months of treatment with full-dose warfarin with a target international normalized ratio (INR) between 2.0 and 3.0. However, for long-term management, no therapeutic agent has shown an acceptable benefit-to-risk ratio. METHODS Patients with idiopathic venous… (More)

5 Figures and Tables


  • Presentations referencing similar topics